Bioscience Neutraceuticals, Inc.
DEVV
←Back to Recent Filings
| Filing |
DATE |
FP |
FY |
End Date |
URL |
VIEW |
|
| 10-K |
3/30/2020 |
Q4 |
2019 |
12/31/2019
|
SEC |
view |
|
| 10-Q |
11/12/2019 |
Q3 |
2019 |
9/30/2019
|
SEC |
view |
|
| 10-Q |
8/12/2019 |
Q2 |
2019 |
6/30/2019
|
SEC |
view |
|
| 10-Q |
5/15/2019 |
Q1 |
2019 |
3/31/2019
|
SEC |
view |
|
| 10-K |
4/9/2019 |
Q4 |
2018 |
12/31/2018
|
SEC |
view |
|
| 10-Q |
1/9/2019 |
Q3 |
2018 |
9/30/2018
|
SEC |
view |
|
| 10-Q |
11/8/2018 |
Q2 |
2018 |
6/30/2018
|
SEC |
view |
|
| 10-Q |
5/14/2018 |
Q1 |
2018 |
3/31/2018
|
SEC |
view |
|
| 10-K |
4/12/2018 |
Q4 |
2017 |
12/31/2017
|
SEC |
view |
|
| 10-Q |
12/7/2017 |
Q3 |
2017 |
9/30/2017
|
SEC |
view |
|
| 10-Q |
10/11/2017 |
Q2 |
2017 |
6/30/2017
|
SEC |
view |
|
| 10-Q |
5/22/2017 |
Q1 |
2017 |
3/31/2017
|
SEC |
view |
|
| 10-K |
3/31/2017 |
Q4 |
2016 |
12/31/2016
|
SEC |
view |
|
| 10-Q |
11/10/2016 |
Q3 |
2016 |
9/30/2016
|
SEC |
view |
|
| 10-Q |
8/11/2016 |
Q2 |
2016 |
6/30/2016
|
SEC |
view |
|
| 10-Q |
5/11/2016 |
Q1 |
2016 |
3/31/2016
|
SEC |
view |
|
| 10-K/A [Amend] |
4/8/2016 |
Q4 |
2015 |
12/31/2015
|
SEC |
view |
|
| 10-K |
3/28/2016 |
Q4 |
2015 |
12/31/2015
|
SEC |
view |
|
| 10-Q |
10/29/2015 |
Q3 |
2015 |
9/30/2015
|
SEC |
view |
|
| 10-Q/A [Amend] |
10/28/2015 |
Q1 |
2015 |
3/31/2015
|
SEC |
view |
|
| 10-K/A [Amend] |
10/28/2015 |
Q4 |
2014 |
12/31/2014
|
SEC |
view |
|
| 10-Q/A [Amend] |
10/21/2015 |
Q2 |
2015 |
6/30/2015
|
SEC |
view |
|
| 10-Q |
7/28/2015 |
Q2 |
2015 |
6/30/2015
|
SEC |
view |
|
| 10-Q |
5/11/2015 |
Q1 |
2015 |
3/31/2015
|
SEC |
view |
|
| 10-K |
3/12/2015 |
Q4 |
2014 |
12/31/2014
|
SEC |
view |
|
| 10-Q |
11/13/2014 |
Q3 |
2014 |
9/30/2014
|
SEC |
view |
|
| 10-Q |
8/7/2014 |
Q2 |
2014 |
6/30/2014
|
SEC |
view |
|
| 10-Q |
6/20/2014 |
Q1 |
2014 |
3/31/2014
|
SEC |
view |
|